Factor XIII (FXIII) and angiogenesis
- 1 January 2006
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (1) , 19-25
- https://doi.org/10.1111/j.1538-7836.2005.01473.x
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Plasma transglutaminase factor XIII induces microvessel ingrowth into biodegradable hydroxyapatite implants in ratsBiomaterials, 2005
- The biology of VEGF and its receptorsNature Medicine, 2003
- NAB2, a Corepressor of EGR-1, Inhibits Vascular Endothelial Growth Factor-mediated Gene Induction and Angiogenic Responses of Endothelial CellsJournal of Biological Chemistry, 2003
- Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrinsNature Medicine, 2002
- Human Prothrombin Fragment 1 and 2 Inhibit bFGF-Induced BCE Cell GrowthBiochemical and Biophysical Research Communications, 1998
- Factor XIII in Ulcerative Leg Disease: Background and Preliminary Clinical ResultsSeminars in Thrombosis and Hemostasis, 1996
- Involvement of blood coagulation factor XIII in burn healing in the carbon tetrachloride-induced hepatic injury model in ratsInflammation Research, 1995
- Osteopontin, a substrate for transglutaminase and Factor XIII activityBiochemical and Biophysical Research Communications, 1991
- Vitronectin is a substrate for transglutaminasesBiochemical and Biophysical Research Communications, 1988
- Bone healing stimulated by plasma Factor XIII: Osteotomy experiments in sheepActa Orthopaedica, 1985